Disclaimer

Other parties that are named have not been consulted.

Interest as a scientist

I am a scientist and my career is furthered by publishing. My employer as well as funding agencies encourage me to proactively report inventions to be able to claim IP. In the almost complete absence of state or health insurer financed funding for clinical trials that lead to approval of a drug, claiminig IP and cooperation with industry may be the only way to carry a basic research finding all the way to the development and validation of novel, effective therapies.

Statement of interest as an editor

I am Chief Editor of the Journal of Cerebral Blood Flow and Metabolism. I obtain a honorarium in this function.

List of companies for whom I have consulted or for which we have conducted fee for service research

Bayer (Schering)

Carot-Remedy

Daiichi-Sankyo

Dr.Mann Pharma

Jansen

Johnson & Johnson

Maquet

Mitsubishi-Tanabe

ONO-Pharma UK LTD

Quickcool

Sanofi

Shin Poong

 

List of organisations and companies who have given me grants (including travel grants and speaker honoraria)

Bayer (Schering)

BMS

Boehringer-Ingelheim

Sanofi

 

Organisations and Foundations who have funded my work

BMBF

Corona Foundation

DFG

Einstein Foundation

EU

German Israel Science Fountation

Hermann and Lilly Schilling Foundation

Human Frontier Science Program

Humboldt Foundation

National Institutes of Health

Stifterverband für die Deutsche Wissenschaft

Technologiestiftung Berlin

 

Patents

‘Preventive antiinfective therapy in stroke’ (European Patent Office 03714776.6-2123-EP0302246). Patent owner: Charité, Humboldt University Berlin, Patent inventors: Andreas Meisel, Christian Meisel, Konstantin Prass, Elke Halle, Hans-Dieter Volk, Ulrich Dirnagl

Erythropoietin Splice Variants (European Patent office EP05010473). Patent owner: Charité, Humboldt UniversityBerlin. Patent inventors: Andreas Meisel, Josef Priller, Konstantin Prass, Ulrich Dirnagl, Christel Bonnas

This declaration updated 20.2.2015